{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:53:05Z","timestamp":1740163985590,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the \u3000Ministry of Education, Science, and Culture of Japan","award":["18590815"],"award-info":[{"award-number":["18590815"]}]},{"name":"a Grant-in-Aid for Scientific Research from the \u3000Ministry of Education, Science, and Culture of Japan","award":["21590898"],"award-info":[{"award-number":["21590898"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study was to evaluate the effects of administration of overnight 1\u00a0mg dexamethasone on vascular function in patients with nonfunctioning adrenal adenomas (NFA). Flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) were measured to assess vascular function in 22 patients with NFA who had hypertension and\/or diabetes mellitus (DM) and 272 patients without adrenal incidentalomas who had hypertension and\/or DM (control patients with hypertension and\/or DM). FMD and NID were measured in the morning before and after administration of 1\u00a0mg of dexamethasone at 2300\u00a0h in 18 patients with NFA. There were no significant differences in FMD and NID between control patients with hypertension and\/or DM and patients with NFA who had hypertension and\/or DM (3.4\u2009\u00b1\u20092.8% vs. 2.9\u2009\u00b1\u20091.9% and 11.5\u2009\u00b1\u20095.7% vs. 11.4\u2009\u00b1\u20094.3%, P\u2009=\u20090.46, and P\u2009=\u20090.99, respectively). There were no significant differences in vascular function between control patients with hypertension and\/or DM and patients with NFA who had hypertension and\/or DM even after adjustment for cardiovascular risk factors. Overnight 1\u00a0mg dexamethasone increased FMD from 2.4\u2009\u00b1\u20091.9% to 5.3\u2009\u00b1\u20093.2% (P\u2009&lt;\u20090.01) and increased NID from 12.1\u2009\u00b1\u20094.2% to 14.0\u2009\u00b1\u20092.8% (P\u2009&lt;\u20090.01) in patients with NFA. The overnight 1\u00a0mg dexamethasone suppression test does not impair FMD and NID in patients with NFA. Decreases in circulating levels of cortisol may improve vascular function.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold> This study was approved by principal authorities and ethical issues in Japan (URL for Clinical Trial: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.umin.ac.jp\/ctr\/index.htm\">http:\/\/www.umin.ac.jp\/ctr\/index.htm<\/jats:ext-link> Registration Number for Clinical Trial: UMIN000039512).<\/jats:p>","DOI":"10.1038\/s41598-023-48295-y","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:02:47Z","timestamp":1701180167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of overnight 1\u00a0mg dexamethasone on vascular function in patients with nonfunctioning adrenal adenomas"],"prefix":"10.1038","volume":"13","clinical-trial-number":[{"clinical-trial-number":"umin000039512","registry":"10.18810\/umin-japan"}],"author":[{"given":"Shinji","family":"Kishimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Maruhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farina Mohamad","family":"Yusoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5813-3672","authenticated-orcid":false,"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"key":"48295_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero, F. et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637\u2013644. https:\/\/doi.org\/10.1210\/jcem.85.2.6372 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48295_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi, G. et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: A 15-year retrospective study. Lancet Diabetes Endocrinol. 2, 396\u2013405. https:\/\/doi.org\/10.1016\/s2213-8587(13)70211-0 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"48295_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.2442","author":"J Patrova","year":"2023","unstructured":"Patrova, J., Mannheimer, B., Lindh, J. D. & Falhammar, H. Mortality in patients with nonfunctional adrenal tumors. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2023.2442 (2023).","journal-title":"JAMA Intern. Med."},{"key":"48295_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/m16-0547","volume":"165","author":"D Lopez","year":"2016","unstructured":"Lopez, D. et al. \u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: A cohort study. Ann. Intern. Med. 165, 533\u2013542. https:\/\/doi.org\/10.7326\/m16-0547 (2016).","journal-title":"Ann. Intern. Med."},{"key":"48295_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-023-01836-1","volume":"22","author":"V Favero","year":"2023","unstructured":"Favero, V. et al. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors. Cardiovasc. Diabetol. 22, 102. https:\/\/doi.org\/10.1186\/s12933-023-01836-1 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"48295_CR6","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1210\/jc.2013-4064","volume":"99","author":"II Androulakis","year":"2014","unstructured":"Androulakis, I. I. et al. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J. Clin. Endocrinol. Metab. 99, 2754\u20132762. https:\/\/doi.org\/10.1210\/jc.2013-4064 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48295_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/eje-07-0455","volume":"157","author":"BR Walker","year":"2007","unstructured":"Walker, B. R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157, 545\u2013559. https:\/\/doi.org\/10.1530\/eje-07-0455 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"48295_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","volume":"141","author":"L Wei","year":"2004","unstructured":"Wei, L., MacDonald, T. M. & Walker, B. R. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann. Intern. Med. 141, 764\u2013770. https:\/\/doi.org\/10.7326\/0003-4819-141-10-200411160-00007 (2004).","journal-title":"Ann. Intern. Med."},{"key":"48295_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/hrt.2003.020180","volume":"90","author":"PC Souverein","year":"2004","unstructured":"Souverein, P. C. et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 90, 859\u2013865. https:\/\/doi.org\/10.1136\/hrt.2003.020180 (2004).","journal-title":"Heart"},{"key":"48295_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/s0895-7061(00)01201-2","volume":"13","author":"GJ Mangos","year":"2000","unstructured":"Mangos, G. J. et al. Cortisol inhibits cholinergic vasodilation in the human forearm. Am. J. Hypertens. 13, 1155\u20131160. https:\/\/doi.org\/10.1016\/s0895-7061(00)01201-2 (2000).","journal-title":"Am. J. Hypertens."},{"key":"48295_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/nejm199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross, R. Atherosclerosis\u2013an inflammatory disease. N. Engl. J. Med. 340, 115\u2013126. https:\/\/doi.org\/10.1056\/nejm199901143400207 (1999).","journal-title":"N. Engl. J. Med."},{"key":"48295_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1253\/circj.cj-08-1102","volume":"73","author":"Y Higashi","year":"2009","unstructured":"Higashi, Y., Noma, K., Yoshizumi, M. & Kihara, Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J. 73, 411\u2013418. https:\/\/doi.org\/10.1253\/circj.cj-08-1102 (2009).","journal-title":"Circ. J."},{"key":"48295_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer, D. S. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (London, England) 340, 1111\u20131115 (1992).","journal-title":"Lancet (London, England)"},{"key":"48295_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0735-1097(01)01746-6","volume":"39","author":"MC Corretti","year":"2002","unstructured":"Corretti, M. C. et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39, 257\u2013265. https:\/\/doi.org\/10.1016\/s0735-1097(01)01746-6 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"48295_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/eje-08-0707","volume":"160","author":"M Sereg","year":"2009","unstructured":"Sereg, M. et al. Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: A long-term follow-up study. Eur. J. Endocrinol. 160, 647\u2013655. https:\/\/doi.org\/10.1530\/eje-08-0707 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"48295_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","volume":"40","author":"J Etxabe","year":"1994","unstructured":"Etxabe, J. & Vazquez, J. A. Morbidity and mortality in Cushing\u2019s disease: An epidemiological approach. Clin. Endocrinol. 40, 479\u2013484. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02486.x (1994).","journal-title":"Clin. Endocrinol."},{"key":"48295_CR17","doi-asserted-by":"publisher","first-page":"e4928","DOI":"10.1136\/bmj.e4928","volume":"345","author":"L Fardet","year":"2012","unstructured":"Fardet, L., Petersen, I. & Nazareth, I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing\u2019s syndrome: cohort study. BMJ 345, e4928. https:\/\/doi.org\/10.1136\/bmj.e4928 (2012).","journal-title":"BMJ"},{"key":"48295_CR18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht, M. et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189, G1-g42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"48295_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/FJC.0b013e3180cab148","volume":"50","author":"AR Dover","year":"2007","unstructured":"Dover, A. R., Hadoke, P. W., Walker, B. R. & Newby, D. E. Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans. J. Cardiovasc. Pharmacol. 50, 321\u2013326. https:\/\/doi.org\/10.1097\/FJC.0b013e3180cab148 (2007).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"48295_CR20","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1210\/jc.2004-2379","volume":"90","author":"DJ Brotman","year":"2005","unstructured":"Brotman, D. J. et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J. Clin. Endocrinol. Metabol. 90, 3202\u20133208. https:\/\/doi.org\/10.1210\/jc.2004-2379 (2005).","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"48295_CR21","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1172\/jci15481","volume":"110","author":"FP Limbourg","year":"2002","unstructured":"Limbourg, F. P. et al. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Investing. 110, 1729\u20131738. https:\/\/doi.org\/10.1172\/jci15481 (2002).","journal-title":"J. Clin. Investing."},{"key":"48295_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nm0502-473","volume":"8","author":"A Hafezi-Moghadam","year":"2002","unstructured":"Hafezi-Moghadam, A. et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat. Med. 8, 473\u2013479. https:\/\/doi.org\/10.1038\/nm0502-473 (2002).","journal-title":"Nat. Med."},{"key":"48295_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ajh\/hpz091","volume":"32","author":"G Sutton","year":"2019","unstructured":"Sutton, G., Pugh, D. & Dhaun, N. Developments in the role of endothelin-1 in atherosclerosis: A potential therapeutic target?. Am. J. Hypertens. 32, 813\u2013815. https:\/\/doi.org\/10.1093\/ajh\/hpz091 (2019).","journal-title":"Am. J. Hypertens."},{"key":"48295_CR24","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/00004872-199816121-00029","volume":"16","author":"AH Danser","year":"1998","unstructured":"Danser, A. H., Admiraal, P. J., Derkx, F. H. & Schalekamp, M. A. Angiotensin I-to-II conversion in the human renal vascular bed. J. Hypertens. 16, 2051\u20132056. https:\/\/doi.org\/10.1097\/00004872-199816121-00029 (1998).","journal-title":"J. Hypertens."},{"key":"48295_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s004410000309","volume":"303","author":"F Coulet","year":"2001","unstructured":"Coulet, F. et al. Endothelium-independent conversion of angiotensin I by vascular smooth muscle cells. Cell Tissue Res. 303, 227\u2013234. https:\/\/doi.org\/10.1007\/s004410000309 (2001).","journal-title":"Cell Tissue Res."},{"key":"48295_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00004872-199405000-00003","volume":"12","author":"A Sato","year":"1994","unstructured":"Sato, A. et al. Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension. J. Hypertens. 12, 511\u2013516 (1994).","journal-title":"J. Hypertens."},{"key":"48295_CR27","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1210\/clinem\/dgaa561","volume":"105","author":"S Kishimoto","year":"2020","unstructured":"Kishimoto, S. et al. A comparison of adrenalectomy and eplerenone on vascular function in patients with aldosterone-producing adenoma. J. Clin. Endocrinol. Metab. 105, 3474\u20133485. https:\/\/doi.org\/10.1210\/clinem\/dgaa561 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"48295_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1161\/atvbaha.112.300934","volume":"33","author":"T Maruhashi","year":"2013","unstructured":"Maruhashi, T. et al. Nitroglycerine-induced vasodilation for assessment of vascular function: A comparison with flow-mediated vasodilation. Arterioscler. Thromb. Vascul. Biol. 33, 1401\u20131408. https:\/\/doi.org\/10.1161\/atvbaha.112.300934 (2013).","journal-title":"Arterioscler. Thromb. Vascul. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48295-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:11:50Z","timestamp":1701180710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48295-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20975"}}